Valuation (76%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 11.12 | 13.57 |
PEG Ratio (TTM) | 1.07 | 2.71 |
P/S Ratio (TTM) | 1.38 | 1.61 |
P/B Ratio (TTM) | 1.07 | 2.81 |
P/FCF Ratio (TTM) | 7.77 | 7.42 |
Price to 5YR AVG Earnings Ratio | 29.86 | 20.96 |
Price to 5YR AVG FCF Ratio | 9.46 | 12.02 |
Profitability (30%) |
Company | Industry |
---|---|---|
ROA (TTM) | 2.00% | 4.53% |
ROE (TTM) | 10.20% | 21.90% |
Net Profit Margin (TTM) | 12.49% | 11.43% |
ROIC 5YR AVG | -5.97% | 10.69% |
Growth (57%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 17.93% | 12.33% | 15.72% |
Revenue | -18.53% | 0.29% | 2.40% |
Net Income | 17.04% | 9.67% | 11.22% |
Cash Flow | 5.42% | -2.74% | 7.20% |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.02 | 21.13 |
Quick Ratio (TTM) | 0.02 | 21.13 |
D/E Ratio (TTM) | 0.55 | 0.38 |
Interest Coverage (TTM) | 3.34 | 19.68 |
Piotroski F-Score | 7 | 7 |
Altman Z-Score | 0.36 | 1.67 |
LTL to 5YR AVG FCF | 4.06 | 1.39 |
Shares Outstanding Growth 5YR AVG | -6.54% | -2.18% |